Quantcast

Latest Clinical trial Stories

2014-09-03 12:31:52

Nearly 20 New Multi-Year iMedNet Agreements Signed Year-to-Date MINNETONKA, Minn., Sept. 3, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that sponsors and CROs around the world are increasingly selecting iMedNet(TM) EDC as their eClinical solution of choice. New iMedNet customers include multiple Top 10 Clinical Research Organizations (CROs) as well as Top 10 pharmaceutical/animal...

2014-09-03 12:27:51

MUMBAI, India, September 3, 2014 /PRNewswire/ -- Now, Chinese regulations on medical devices are undergoing earthshaking changes. China's new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid economic and population growth over the past three decades. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical Devices" to try to completely change...

2014-09-03 08:33:41

PLYMOUTH MEETING, Pa., Sept. 3, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in New York, NY and at the Aegis Capital Healthcare and Technology Conference in Las Vegas, NV. Dr. J. Joseph Kim, Inovio's Chief Executive Officer, will provide a corporate overview of the Company and its programs at each of these events. Rodman & Renshaw Investment Conference September...

2014-09-03 08:33:09

MARLBOROUGH, Mass., Sept. 3, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the Rodman & Renshaw 16(th) Annual Global Investment Conference on Wednesday, September 10, 2014 at 12:05 p.m. EST. Dr....

2014-09-03 08:32:46

ST. PAUL, Minn., Sept. 3, 2014 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the publication of results from the Company's ReCharge Pivotal Trial of VBLOC Vagal Blocking Therapy delivered via the Maestro® System for the treatment of patients with obesity in the September 3, 2014 issue (doi:10.1001/jama.2014.10540) of The...

2014-09-03 08:32:32

- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - CAMBRIDGE, Mass. and NORTH CHICAGO, Ill., Sept. 3, 2014 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer....

2014-09-02 12:28:35

NEW YORK CITY, New York, September 2, 2014 /PRNewswire/ -- Persistence Market Research(http://www.persistencemarketresearch.com) "Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019" the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Browse the full Global Market Study...

2014-09-02 12:28:32

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB: AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has received independent internal review board (IRB) approval to initiate human clinical studies of Hemopurifier® therapy at DaVita MedCenter Dialysis located in Houston, Texas. http://photos.prnewswire.com/prnvar/20090325/LA88762LOGO-b...

2014-09-02 08:31:36

PHILADELPHIA, Sept. 2, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has developed a recommended approach for protecting personal data in Clinical Study Reports (CSRs) that are shared with researchers, patients and others. The document describes an approach to apply when redacting or removing personal information from CSRs and other related clinical trial documents, and is available here. The goal of the TransCelerate CSR Redaction...

2014-09-02 08:30:36

Data from Multi-Center, Placebo-Controlled Study Anticipated in Q1 2015 SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'